Alicia Daum, PA
Physician Assistant · Sioux Falls, SDNPI 1760992192
Payments from drug & device makers
Across 108 payments — averaging $15.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$465
- Lilly USA, LLC$257
- Johnson & Johnson$148
- Novo Nordisk$130
- Amgen$110
- Merck$69
- plus $469 from 20 others
What the payments were for
- Food & beverage$1,648100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 34 | $465 |
| Lilly USA, LLC | 14 | $257 |
| Johnson & Johnson | 10 | $148 |
| Novo Nordisk | 9 | $130 |
| Amgen | 7 | $110 |
| Merck | 5 | $69 |
| Grifols USA, LLC | 2 | $40 |
| AstraZeneca | 3 | $37 |
| Boehringer Ingelheim | 2 | $37 |
| Phathom Pharmaceuticals, Inc. | 2 | $35 |
| Mylan Specialty L.p. | 2 | $31 |
| Viatris Specialty LLC | 1 | $28 |
| GSK | 2 | $28 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $28 |
| Pfizer | 2 | $28 |
| Daiichi Sankyo Inc. | 1 | $19 |
| Sanofi Pasteur Inc. | 1 | $19 |
| Inspire Medical Systems, Inc. | 1 | $17 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $16 |
| Astellas Pharma US Inc | 1 | $16 |
| E.r. Squibb & Sons, L.L.C. | 1 | $16 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
| Actelion Pharmaceuticals US, Inc. | 1 | $15 |
| Dynavax Technologies Corporation | 1 | $14 |
| Bayer | 1 | $14 |
| Abbott | 1 | $13 |
How this compares
$1,648 in reported general payments places this provider in the 85th percentile of 548 physician assistant providers in South Dakota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 21 | $19,720 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 27 | $19,640 |
| TrulicityDulaglutide | 14 | $18,460 |
| Trijardy XrEmpaglifloz/Linaglip/Metformin | 22 | $17,605 |
| XareltoRivaroxaban | 11 | $9,814 |
| Baclofen | 13 | $2,817 |
| Gabapentin | 76 | $2,515 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 76 | $2,087 |
| Insulin Lispro Kwikpen U-100Insulin Lispro | 12 | $2,064 |
| Dexlansoprazole DrDexlansoprazole | 13 | $1,833 |
| Omeprazole | 122 | $1,607 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 36 | $1,426 |
| Atorvastatin Calcium | 136 | $1,276 |
| Pantoprazole Sodium | 53 | $1,152 |
| Oxybutynin Chloride ErOxybutynin Chloride | 35 | $1,089 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimSynjardy Xr, Trijardy Xr | $37 | $37,24549 claims |
| GSKTrelegy Ellipta | $28 | $19,72021 claims |
| Lilly USA, LLCTrulicity | $257 | $18,46014 claims |
| Johnson & JohnsonXarelto | $148 | $9,81411 claims |
| AbbVieSynthroid | $465 | $1,08216 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 548 physician assistant providers in South Dakota.
Other physician assistant in Sioux Falls
- Kimberly NelsonSioux Falls$11K
- Christina PekoskeSioux Falls$9K
- Rachel HotvetSioux Falls$8K
- Gabriel PenaredondoSioux Falls$7K
- Virginia LemmeSioux Falls$6K
- Kathrine JibbenSioux Falls$6K
- Austen FagerlandSioux Falls$6K
- Cheryle BrandtSioux Falls$6K
- Rachelle BroveleitSioux Falls$5K
- Stephanie SteltonSioux Falls$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.